Gentamicin Injection recall
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor…
Why was Gentamicin Injection recalled?
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
- Product
- Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor…
- Recalling firm
- Eugia US LLC
- Quantity
- 48,000 vials
- Distribution
- Nationwide in the USA
- Recall date
- June 25, 2025
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)